Mantini, Giovanna
 Distribuzione geografica
Continente #
EU - Europa 3.073
NA - Nord America 3.014
AS - Asia 613
SA - Sud America 22
AF - Africa 18
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 6.767
Nazione #
US - Stati Uniti d'America 2.953
DE - Germania 1.401
SE - Svezia 538
CN - Cina 394
UA - Ucraina 270
IT - Italia 237
FR - Francia 145
IE - Irlanda 139
IN - India 110
GB - Regno Unito 109
PL - Polonia 56
FI - Finlandia 51
CA - Canada 50
TR - Turchia 48
BE - Belgio 35
CZ - Repubblica Ceca 28
AU - Australia 15
CI - Costa d'Avorio 14
IR - Iran 14
SG - Singapore 14
RU - Federazione Russa 13
BR - Brasile 11
BZ - Belize 10
CH - Svizzera 8
EU - Europa 8
JP - Giappone 8
NL - Olanda 8
CL - Cile 6
PT - Portogallo 6
AT - Austria 5
ES - Italia 5
KR - Corea 5
NO - Norvegia 5
RO - Romania 4
ID - Indonesia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BG - Bulgaria 2
DZ - Algeria 2
GR - Grecia 2
HU - Ungheria 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
TW - Taiwan 2
VN - Vietnam 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
BD - Bangladesh 1
BH - Bahrain 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
HK - Hong Kong 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 6.767
Città #
Chandler 666
Ashburn 225
Jacksonville 156
Ann Arbor 145
Dublin 138
San Mateo 138
Nanjing 106
Nürnberg 100
Dearborn 98
Houston 92
Woodbridge 83
Wilmington 81
Boston 59
New York 58
Redwood City 57
Marseille 51
Warsaw 48
Bremen 46
Nanchang 46
Cattolica 45
Fairfield 45
Princeton 44
Izmir 43
Milan 38
Redmond 38
Lawrence 37
Beijing 34
Brussels 34
Munich 30
San Jose 27
Hebei 22
Leawood 22
North York 21
Seattle 21
Kunming 20
Los Angeles 20
Tianjin 19
Hangzhou 18
Jiaxing 18
Rome 18
Shenyang 17
Mountain View 16
Toronto 15
Abidjan 14
Shanghai 14
Boardman 13
Chicago 13
Albuquerque 12
Enterprise 12
San Diego 12
Zhengzhou 12
Andover 11
Changsha 11
Washington 11
Belize City 10
Falls Church 9
Fremont 9
Hefei 9
University Park 9
Cambridge 8
Lancaster 8
Las Vegas 8
Norwalk 8
Pune 8
Castelnuovo 7
Saint Louis 7
Singapore 7
Auburn Hills 6
Changchun 6
Helsinki 6
Jinan 6
Augusta 5
Detroit 5
Monmouth Junction 5
Ottawa 5
Phoenix 5
San Francisco 5
Atlanta 4
Bari 4
Berlin 4
Bern 4
Bologna 4
Brno 4
Fuzhou 4
Kraków 4
London 4
Melbourne 4
Moscow 4
Philadelphia 4
São Paulo 4
Vienna 4
Xian 4
Ardabil 3
Buffalo 3
Columbus 3
Düsseldorf 3
Edmonton 3
Guangzhou 3
Indiana 3
Jakarta 3
Totale 3.435
Nome #
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 222
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 215
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 204
Pros-IT CNR: an Italian prostate cancer monitoring project 204
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 164
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 156
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 156
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 154
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 138
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 136
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 135
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 128
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 123
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 122
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 122
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 121
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 120
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 113
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 112
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 111
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 109
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 108
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 108
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 108
Radiotherapy vs Follow up in the treatment of pathological stage Ia and Ib non small cell lung cancer. Early stopped analysis of a randomized controlled study. 106
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 104
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 102
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 98
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 96
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 94
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 94
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 94
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 92
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 91
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. 90
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 87
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis. 86
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 83
Role of radiotherapy in the treatment of fibrosarcoma of the spermatic cord: a case report and review of the literature 79
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 79
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 76
Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome 75
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 74
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 73
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 72
Can automation in radiotherapy reduce costs? 70
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 70
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 70
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 67
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 63
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 60
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 60
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 60
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 58
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 57
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 57
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 56
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 54
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy 54
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 54
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 54
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 52
Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy 51
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 50
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 48
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 45
Breakthrough pain management in patients undergoing radiotherapy: A national survey on behalf of the Palliative and Supportive Care Study Group 43
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 43
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 43
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 43
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 41
Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study 38
BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer 33
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 30
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 29
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 28
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 25
Impact of dose and volume on radiation-induced mucositis 19
Spider: Managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system 12
Preoperative radiotherapy in gastric cancer: CTV definition for conformal therapy according to tumor location 12
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 12
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 8
Chemoradiation with raltitrexed (TOMUDEX) in preoperative treatment of stage II-III resectable rectal cancer: A phase II study 7
Quality handbook in radiotherapy: personal experience 7
External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study 4
Totale 6.921
Categoria #
all - tutte 21.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019201 0 0 0 0 0 0 0 0 0 82 75 44
2019/20201.203 180 64 48 64 134 111 124 47 120 57 174 80
2020/2021783 54 72 38 94 148 53 84 27 86 37 81 9
2021/2022849 77 57 16 58 52 45 27 134 34 67 132 150
2022/20231.770 254 250 149 303 102 208 88 126 203 13 47 27
2023/2024548 33 207 20 69 29 95 16 55 11 13 0 0
Totale 6.921